Track the Ambu A/S share price and the full management transaction log of the company, a publicly traded company based in Denmark. Shares trade on the DK market, under the oversight of Finanstilsynet DK. Operating in the Health Care sector, Ambu A/S has recorded 228 public disclosures. Market capitalisation: €18.7bn. The latest transaction was reported on 9 June 2026 (Purchase). Among the most active insiders: Britt Meelby Jensen. The full history is accessible without an account.
228
Insider Decl.
n/a
Thresholds
€6m
13 ops.
Buy Volume
€385m
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ambu A/S Buy (bullish), based on 8 analysts. Average price target: DKK 87.30.
38Σ signal
Buys €6m€385m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,315 of 29,062 companies
52.4
score / 100
Value
40
Quality
65
FCF yld2.8%
Earn yld1.3%
EV/EBITDA18.7x
ROE8.4%
Gross mgn59%
Net mgn4.4%
Debt/EBITDA0.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
328 shares@ DKK 235.810.0000% mcap0.0% of flowShareOutside a trading venue (shares received after vesting will be listed onISINISIN DK0060946788DK:1034032
625 shares@ DKK 235.810.0001% mcap0.0% of flowShareOutside a trading venue (shares received after vesting will be listed onISINISIN DK0060946788DK:1034030
39,000 shares@ DKK 190.080.0029% mcap0.3% of flowShareNasdaq CopenhagenISINISIN DK0060946788DK:976293
25 of 228 declarations
Acerca de Ambu A/S
Ambu A/S es una empresa danesa que se especializa en el desarrollo y la fabricación de dispositivos médicos. Se enfoca principalmente en productos para reanimación, anestesia y monitoreo de pacientes.